The intracellular S1P, on the other hand, promotes cancer progression in a receptor-independent manner [11], [12], by either mediating calcium release from endoplasmic reticulum, or by interacting with its intracellular targets, such as HDAC and TNF receptor-associated factor 2 (TRAF2) [20]. The gene discussed is TRAF2; the disease is cancer.